US2011110894A1PendingUtilityA1
Methods, compositions and systems for controlling fouling of a membrane
Est. expiryNov 10, 2029(~3.3 yrs left)· nominal 20-yr term from priority
Y02W10/10C02F 3/1268C02F 3/2853C02F 2303/20C02F 3/34
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides methods and compositions for improving permeability and flux in a membrane filtration system, especially in water or wastewater treatment processes.
Claims
exact text as granted — not AI-modified1 . A method of improving the permeability of a membrane used in a process or the flux through
a membrane used in a process, comprising subjecting the membrane to one or more microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
2 . The method of claim 1 , wherein microorganisms includes one or more bacterial strains capable of reducing or preventing undesirable biofilm formation on the membrane.
3 . The method of claim 1 , wherein the one or more microorganisms are spore forming microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
4 . The method of claim 2 , wherein the one or more bacterial strains are spore forming bacterial strains capable of reducing or preventing undesirable biofilm formation on the membrane.
5 . The method of claim 1 , wherein microorganisms includes one or more bacterial strains, one or more fungal strains, or a mixture of one or more bacterial and fungal strains capable of reducing or preventing undesirable biofilm formation on the membrane.
6 . The method of claim 1 , wherein the membrane is subjected to a strain of Bacillus spp., e.g., Bacillus amyloliquefaciens; Bacillus atrophaeus; Bacillus azotoformans; Bacillus brevis; Bacillus cereus; Bacillus circulans; Bacillus clausii; Bacillus coagulans; Bacillus firmus; Bacillus flexus; Bacillus fusiformis; Bacillus globisporus; Bacillus glucanolyticus; Bacillus infermus; Bacillus laevolacticus; Bacillus licheniformis; Bacillus marinus; Bacillus megaterium; Bacillus mojavensis; Bacillus mycoides; Bacillus pallidus; Bacillus parabrevis; Bacillus pasteurii; Bacillus polymyxa; Bacillus popiliae; Bacillus pumilus; Bacillus sphaericus; Bacillus subtilis; Bacillus thermoamylovorans ; or Bacillus thuringiensis.
7 . The method of claim 1 , wherein the improved flux allows for the use of a membrane having a smaller membrane surface area.
8 . The method of claim 1 , wherein the membrane is part of a membrane bioreactor system.
9 . The method of claim 1 , wherein the process is a water treatment process.
10 . The method of claim 1 , wherein the one or more microorganisms are capable of preventing or reducing biofilm formation through quorum sensing inhibition.
11 . The method of claim 6 , wherein the one or more strains of Bacillus are selected from the group consisting of:
the Bacillus megaterium strain having the deposit accession number ATCC 14581; the Bacillus pumilus strain having the deposit accession number ATCC 700385; the Paenibacillus azotofixans strain having the deposit accession number ATCC 35681; the Bacillus licheniformis strain having the deposit accession number NRRL B-50014; the Bacillus licheniformis strain having the deposit accession number NRRL B-50015; the Bacillus pumilus strain having the deposit accession number NRRL B-50016; the Bacillus subtilis strain having the deposit accession number ATCC 6051A; the Bacillus amyloliquefaciens strain having the deposit accession number NRRL B-50017; the Bacillus amyloliquefaciens strain having the deposit accession number NRRL B-50018; the Bacillus subtilis strain having the deposit accession number NRRL B-50136; the Bacillus amyloliquefaciens strain having the deposit accession number NRRL B-50141; the Bacillus amyloliquefaciens strain having the deposit accession number NRRL B-50304; the Bacillus amyloliquefaciens strain having the deposit accession number NRRL B-50349; the Bacillus megaterium strain having the deposit accession number PTA-3142; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7541; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7542; the Bacillus atrophaeus strain having the deposit accession number PTA-7543; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7544; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7545; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7546; the Bacillus subtilis strain having the deposit accession number PTA-7547; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7549; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7790; the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7791; the Bacillus atrophaeus strain having the deposit accession number PTA-7792; and the Bacillus amyloliquefaciens strain having the deposit accession number PTA-7793; or a mixture of two or more of the strains.
12 . A method of increasing critical flux of a membrane used in a process, comprising subjecting the membrane to one or more microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
13 . The method of claim 12 , wherein microorganisms includes one or more bacterial strains, capable of reducing or preventing undesirable biofilm formation on the membrane.
14 . The method of claim 12 wherein the one or more microorganisms are spore forming microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
15 . The method of claim 13 wherein the one or more bacterial strains are spore forming bacterial strains capable of reducing or preventing undesirable biofilm formation on the membrane.
16 . The method of claim 12 , wherein microorganisms includes one or more bacterial strains, one or more fungal strains, or a mixture of one or more bacterial and fungal strains capable of reducing or preventing undesirable biofilm formation on the membrane.
17 . The method of claim 12 , wherein the membrane is part of a membrane bioreactor system.
18 . The method of claim 12 , wherein the process is a water treatment process.
19 . A method of reducing or preventing fouling of a membrane used in a process, comprising subjecting the membrane to one or more microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
20 . The method of claim 19 , wherein microorganisms includes one or more bacterial strains capable of reducing or preventing undesirable biofilm formation on the membrane.
21 . The method of claim 19 , wherein the one or more microorganisms are spore forming microorganisms capable of reducing or preventing undesirable biofilm formation on the membrane.
22 . The method of claim 20 , wherein the one or more bacterial strains are spore forming bacterial strains capable of reducing or preventing undesirable biofilm formation on the membrane.
23 . The method of claim 19 , wherein microorganisms includes one or more bacterial strains, one or more fungal strains, or a mixture of one or more bacterial and fungal strains capable of reducing or preventing undesirable biofilm formation on the membrane.
24 . The method of claim 19 , wherein the membrane is part of a membrane bioreactor system.
25 . The method of claim 19 , wherein the process is a water treatment process.
26 . The method of claim 19 , wherein the one or more microorganisms are capable of preventing or reducing biofilm formation through quorum sensing inhibition.Join the waitlist — get patent alerts
Track US2011110894A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.